Jennifer L Holter-Chakrabarty

9PUBLICATIONS
71CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 12, 2025
Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial.

Everett H Meyer, Amandeep Salhotra, Arpita P Gandhi

|Nov 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).

Robert Jeraj, Fenghai Duan, Ryan J Mattison

|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn, Megan M Herr, Min Chen

|Dec 13, 2024
18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation.

Jennifer Holter-Chakrabarty, Lacey McNally, John Levine

|Dec 05, 2024
Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2-Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy.

Murali K Mamidi, Sutapa Sinha, Mariana T Mendez

|Oct 17, 2022
Incidence and risk factors for graft failure in the modern era of cord blood transplantation.

Jennifer Holter Chakrabarty, Joshua Glover, Sara Schmidt

Pageof 2

Frequent Collaborators

4 joint publications

Joshua Glover

4 joint publications

Sara Vesely

1 joint publications

Murali K Mamidi

1 joint publications

Sutapa Sinha